INCOME TAXES (Details Narrative) (USD $)	Jun. 30, 2013
Income Tax Disclosure [Abstract]
Deferred Tax Asset, attributable to net operating loss carry forwards	$ 5,946,935
Net operating loss carry forwards	17,490,897
Net Operating Loss Carry forwards acquired in reverse acquisition of BMSG	38,616
Net Operating Loss Carry forwards attributable to Bio-Matrix Scientific Group, Inc., BMSG, Regen and Entest	17,454,281
Deferred tax assets, reduced from recorded valuation allowance	$ 0